|
|
| | PLATELET FACTOR 4 (58-70) (HUMAN) Basic information |
| Product Name: | PLATELET FACTOR 4 (58-70) (HUMAN) | | Synonyms: | H-PRO-LEU-TYR-LYS-LYS-ILE-ILE-LYS-LYS-LEU-LEU-GLU-SER-OH;platelet factor 4 fragment 58-70 human;PF4 (58-70) (HUMAN);PLATELET FACTOR 4 (58-70) (HUMAN);PLATELET FACTOR-4 (HUMAN, 58-70);PRO-LEU-TYR-LYS-LYS-ILE-ILE-LYS-LYS-LEU-LEU-GLU-SER;L-Prolyl-L-leucyl-L-tyrosyl-L-lysyl-L-lysyl-L-isoleucyl-L-isoleucyl-L-lysyl-L-lysyl-L-leucyl-L-leucyl-L-α-glutamyl-L-serine;PLATELET FACTOR 4 (58-70) (HUMAN) USP/EP/BP | | CAS: | 82989-21-7 | | MF: | C76H133N17O18 | | MW: | 1572.97 | | EINECS: | | | Product Categories: | | | Mol File: | 82989-21-7.mol |  |
| | PLATELET FACTOR 4 (58-70) (HUMAN) Chemical Properties |
| Boiling point | 1739.7±65.0 °C(Predicted) | | density | 1+-.0.06 g/cm3(Predicted) | | storage temp. | −20°C | | pka | 2.95±0.10(Predicted) | | form | Solid | | color | White to off-white | | Sequence | Pro-Leu-Tyr-Lys-Lys-Ile-Ile-Lys-Lys-Leu-Leu-Glu-Ser |
| | PLATELET FACTOR 4 (58-70) (HUMAN) Usage And Synthesis |
| Uses | Platelet Factor 4 (58-70), human, a peptide based on the amino acid sequence corresponding to residues 58-70 of platelet factor-4 (PF-4), contains the major heparin-binding domain, which is not sufficient for full antiangiogenic activity[1]. | | References | [1] Jouan V, et al. Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood. 1999 Aug 1;94(3):984-93. PMID:10419890 |
| | PLATELET FACTOR 4 (58-70) (HUMAN) Preparation Products And Raw materials |
|